Introduction and hypothesis Women have a 20% risk of developing a urinary tract infection (UTI) following urogynecologic surgery. This study assessed the association of postoperative UTI with bacteria in preoperative samples of catheterized urine. Methods Immediately before surgery, vaginal swabs, perineal swabs, and catheterized urine samples were collected, and the V4 region of the 16S ribosomal RNA (rRNA) gene was sequenced. The cohort was dichotomized in two ways: (1) standard day-ofsurgery urine culture result (positive/negative), and (2) occurrence of postoperative UTI (positive/negative). Characteristics of bladder, vaginal, and perineal microbiomes were assessed to identify factors associated with postoperative UTI. Results Eighty-seven percent of the 104 surgical patients with pelvic organ prolapse/urinary incontinence (POP/UI) were white; mean age was 57 years. The most common genus was Lactobacillus, with a mean relative abundance of 39.91% in catheterized urine, 53.88% in vaginal swabs, and 30.28% in perineal swabs. Two distinct clusters, based on dispersion of catheterized urine (i.e., bladder) microbiomes, had highly significant (p < 2.2-16) differences in age, microbes, and postoperative UTI risk. Postoperative UTI was most frequently associated with the bladder microbiome; microbes in adjacent pelvic floor niches also contributed to UTI risk. UTI risk was associated with depletion of Lactobacillus iners and enrichment of a diverse mixture of uropathogens. Conclusions Postoperative UTI risk appears to be associated with preoperative bladder microbiome composition, where an abundance of L. iners appears to protect against postoperative UTI.
Introduction
Hospital-acquired urinary tract infections (UTI) are an important clinical quality metric. Many adult women with pelvic organ prolapse (POP) and/or stress urinary incontinence (SUI) undergo urogynecologic surgery. Approximately 7-24% of these surgical patients will develop a postoperative UTI despite prophylactic antibiotics and other preventive measures [1] [2] [3] . There is a transient increase in UTI risk in the early postoperative period following insertion of retropubic tension-free vaginal tape, regardless of concomitant prolapse repair [1] . Postoperative UTI is commonly attributed to the introduction of a uropathogen into the lower urinary tract during instrumentation (catheterization and/or cystoscopy). The recent discovery and confirmation of live bacteria in the bladder of adult women (bladder microbiota) [4] [5] [6] [7] [8] [9] [10] , however, provides a basis for alternate etiologies for postoperative UTI, a potentially preventable adverse event.
Multiple perioperative events have potential to influence the bladder microbiota, including urinary tract instrumentation and systemic antibiotics used to prevent surgical infection. Resilience and recovery of the postoperative bladder microbiota have not been described; however, the resilience/recovery process is likely to vary across individuals based on the unique characteristics of their bladder microbiota and their overall physiology. Presurgical disruption (dysbiosis) of the microbiota is likely to be associated with an increased risk of postoperative dysbiosis, potentially increasing postoperative UTI risk. We previously described the use of a simple standard urine culture as a tool for identifying a subgroup of women at increased risk for postoperative UTI [11] . Compared with patients with negative standard urine cultures on the day of surgery, patients with a positive (>1000 CFU/ml) culture were almost six times more likely to develop a postoperative UTI.
Here, we expand our analysis of this cohort of women, using 16S ribosomal RNA (rRNA) gene sequencing to characterize day-of-surgery (DOS) bladder, vaginal, and perineal microbiomes and correlate these findings with UTI risk following urogynecological surgery.
Methods

Study design
Recruitment and initial characterization of the primary study cohort was previously described [11] . Briefly, after institutional review board approval, we approached women undergoing a vraiety of common urogynecologic procedures (slings and prolapse repair, both transvaginal and laparoscopically) to treat pelvic organ prolapse (POP) and/or stress urinary incontinence (SUI) at Loyola University Medical Center. The primary objective of this analysis was to determine correlations of pelvic floor bacteria with UTI risk. Therefore, we restricted this analytic cohort to the 104 participants with sequencepositive samples from urine, vagina, and perineum. Clinical data, such as age, body mass index (BMI), medical comorbidities, type of POP/UI surgery, DOS status, and hormone status were extracted from the electronic medical record. Hormone status was determined clinically and categorized as premenopausal, postmenopausal on hormones, or postmenopausal not on hormones.
Following induction of anesthesia and prior to systemic antibiotic administration or any surgery, we collected vaginal and perineal samples using cotton swabs and a standardized collection protocol; we collected the urine sample via a urinary catheter placed consistent with surgical protocols. A portion of the DOS urine sample, obtained preoperatively, was sent for standard clinical urine culture, and a portion was stored at -80 ºC in 10% AssayAssure (Sierra Molecular, Incline Village, NV, USA) prior to DNA isolation for sequencing. Each swab was suspended in 1 ml of phosphate-buffered saline (PBS), and the suspension was stored at -80°C in 10% AssayAssure prior to DNA isolation for sequencing.
Similar to our prior report on postoperative UTI risk [11] , patients were queried on UTI symptoms during the 6-week postoperative period, and catheterized urine samples were obtained, as clinically indicated. A positive urine culture was defined as at least 1000 bacterial colony-forming units per milliliter of catheterized urine identified on standard microbial culture techniques.
DNA isolation from urine
DNA isolation, polymerase chain reaction (PCR) amplification, and 16S rRNA gene sequencing of urine cultures has been described previously [10] . To avoid contamination, isolation of DNA was performed in a laminar flow hood. Genomic DNA was extracted from 1 ml of urine using previously validated protocols developed for the Human Microbiome Project [4, 10, 12] . To isolate genomic DNA from urine samples, this protocol includes the addition of peptidoglycan-degrading enzymes, mutanolysin, and lysozyme, that ensure robust lysis of Gram-positive and Gramnegative species [12] . Briefly, 1 ml of urine was centrifuged at 13,500 rpm for 10 min, and the resulting pellet was resuspended in 200 μl of filter-sterilized buffer consisting of 20 mM Tris-Cl (pH 8), 2 mM ethylenediaminetetraacetate (EDTA), 1.2% Triton X-100, and 20 μg/ml lysozyme and supplemented with 30 μl of filter-sterilized mutanolysin (5000 U/ml; Sigma-Aldrich, St. Louis, MO, USA). The mixture was incubated for 1 h at 37°C, and the lysates were processed through the DNeasy blood and tissue kit (Qiagen, Valencia, CA, USA), according to the manufacturer's protocol. The DNA was eluted into 50 μl of buffer AE, pH 8.0, and stored at −20°C.
The hypervariable region 4 (V4) of the bacterial 16S rRNA gene was amplified via a two-step PCR protocol, as described previously [4, 10] . Briefly, in the first amplification, the V4 region was amplified using Illumina MiSeq modified universal primers 515F and 806R. Extraction-negative controls (no urine or swab suspension) and PCR-negative controls (no template) were included to assess the contribution of extraneous DNA from reagents. Ten-microliter aliquots of each reaction mixture were run on a 1% agarose gel. Samples containing a band of approximately 360 bp were considered PCRpositive and subjected to further library preparation. Samples with no visible amplified product were considered PCRnegative and not processed further. The PCR-positive reaction mixtures were diluted 1:50 and amplified for an additional ten cycles using primers encoding the required adapter sequences for Illumina MiSeq sequencing and an eightnucleotide sample index. The PCR reaction was purified and size selected using Agencourt AMPure XP-PCR magnetic beads (Beckman Coulter, Pasadena, CA, USA). Each sample was quantified using the Qubit fluorometeric system (Thermo-Fisher, Waltham, MA, USA). The samples were pooled, quantified to a standard volume, and placed in the 2 × 250-bp sequencing reagent cartridge, according to the manufacturer's instructions (Illumina, San Diego, CA, USA).
Because urine samples typically contain small amounts of bacteria (i.e., low biomass), amplification and sequencing was performed in duplicate (technical replicates) and samples classified as either sequence-positive or sequence-negative. A sequence-positive sample was one in which DNA was amplified from both replicates and, if present, the dominant taxon (representing >50% of sequences from the sample) was the same in both replicates. For each sequence-positive urine sample, both replicates were used for further analysis. Because they usually contain high biomass, vaginal and perineal swabs were sequenced a second time only if the first attempt was negative. For this analysis, sequence-negative urines and swabs were not analyzed further.
Data analysis
Sample barcodes and sequencing primers were removed using the Illumina proprietary MiSeq postsequencing software. The mothur program (v1.37.4) was used to process raw sequences by following the recommended MiSeq standard operating procedure [13] . Briefly, mothur produced 16S contigs by combining the paired end reads based on overlapping nucleotides in the sequence reads; contigs of incorrect length for the V4 region (<290 bp, >300 bp) and/or contigs containing ambiguous bases were removed. Chimeric sequences were removed using UCHIME within the mothur package [14] . Subsampling at a depth of 5000 sequences was performed to correct for different sequencing depth of each sample. The sequences were clustered into species-level operational taxonomic units (OTUs), with identity cutoff at 97% [15] . The OTUs were classified using RDP classifier (v2.11) at the genus level [15] and Bayesian Lowest Common Ancestor (BLCA) [16] at the species level. All statistical analyses were performed using open-source R packages. For each sample, alpha diversity indices, Chao1, ACE, Shannon, and Simpson were calculated using the vegan [17] package in R. Principal coordinate analysis (PCoA) (ape package in R [18] ) was applied to cluster microbiome samples based on BrayCurtis dissimilarities (ecodist package in R [19] ). K-means clustering was applied to confirm PCoA clustering results. Dispersion of the PCoA clusters was compared using the betadisper command in R vegan package [20, 21] . The permutation analysis of variance (PERMANOVA) test, using the vegan [17] package in R, was performed to determine whether there is statistically significant separation between different sample groups (e.g., urine vs. vagina). Student's t test and chi-squared test were applied to compare the demographic and clinical variables (e.g., age and premenopausal status) among different urogynecologic surgical groups (i.e., SUI and POP). Using the glmmADMB package [22] in R, generalized linear regression with a negative binomial model was applied to identify the association between bacterial abundance and postoperative UTI status, DOS result, and PCoA clusters. Fisher's exact test was applied to examine the association between DOS/UTI status and PCoA clusters. Multiple testing correction was performed with the standard Benjamini-Hochberg procedure.
Results
Patient characterization
The 104 surgical patients in this analytic cohort includes 94 women who were described in our earlier report [11] and an additional ten women from the same IRB-approved study of postoperative infection in urogynecologic patients. Other than an expected higher proportion of positive urine cultures in these women with sequence-positive urine samples (18.3% vs. 9.5%, p = 0.02), we detected no significant clinical differences in variables between this analytic cohort and the originally described larger cohort (n = 284).
Most (87%) women in this analysis were white; mean age was 57 years ( Table 1) . The group had a typical distribution of indications for urogynecological surgery: 31 (30%) women had surgery for SUI only, 42 (40%) for POP only, and 31 (30%) had combined SUI and POP. Women undergoing POP or SUI/POP surgeries were older than those undergoing surgery for SUI (p < 0.05). Consistent with clinical practice, women who had isolated SUI surgery were more likely to be premenopausal and those having isolated POP surgery were more likely to be postmenopausal (p < 0.05). Of the 17 patients reporting hormone therapy use, 16 reported hormone treatment per oral hormone therapy, one reported transdermal patch use, and two reported vaginal estrogen cream use.
Microbiome characterization
The bacterial sequences detected were classified into 22 phyla, 45 classes, 102 orders, 199 families, and 646 genera. The most common genus was Lactobacillus, with a mean abundance of 39.91% in catheterized urine, 53.88% in vaginal swabs, and 30.28% in perineal swabs (Table 2) . Gardnerella was the only other genus among the five most common genera in all three niches, with a mean abundance of 10.2% in the urine, 11.5% in the vagina, and 5.5% in the perineum. Anaerococcus was common in the vagina (3.9%) and perineum (9.2%) but was not among the five most common genera in urine, whereas Corynebacterium was common in the perineum (9.1%) and urine (6.0%) but not the vagina.
The bladder microbiomes of participants grouped into two distinct clusters based on their bacterial compositions at the genus level: a more dispersed cluster (MDC) and a less dispersed cluster (LDC) (Fig. 1) . The difference in dispersion was highly significant (p < 2.2 × 10
−16
). Women in the LDC were younger (average age 51 years) and their urinary microbiome more likely to contain L. iners (Table 3) .
Women in the MDC were older (average age 59 years) and their urinary microbiomes enriched in a diverse set of pathogens, including members of the family Enterobacteriaceae, the genera Pseudomonas and Staphylococcus,, and the species L. delbrueckii, Actinotignum (formerly Actinobaculum) schaalii, A n a e r o c o c c u s o b e s i e n s i s , C o r y n e b a c t e r i u m tuberculostearicum, Streptococcus anginosus, Aerococcus christensenii, and Anaerococcus murdochii (Table 3) . Table 4 compares LDC and MDC in terms of DOS culture results and postoperative UTI status. Almost all women in the LDC were DOS-negative, and none experienced a postoperative UTI. Thus, most DOS-positive and/or UTI-positive women aligned with the MDC group.
Association of microbes with risk of postoperative UTI Table 5 depicts a PERMANOVA analysis of differences in bacteria composition using Bray-Curtis dissimilarity between the three sampled sites. It reveals that bladder microbiomes differed significantly by postoperative UTI status with or without consideration of the DOS result; in contrast, vaginal and perineal microbiomes did not differ. These findings were consistent at both the genus and OTU levels. Table 6 displays taxa associated with postoperative UTI. In urine, L. iners and an OTU from another Lactobacillus species were abundant and enriched in women who did not experience a postoperative UTI. A less-abundant OTU of the genus Peptoniphilus was also enriched in urine of UTI-negative women. No taxa detected in the vagina were associated with UTI status; however, a few low-abundance taxa detected in the perineum were associated with postoperative UTI, including Bacteroides coagulans and B. fragilis and an OTU in the class β-proteobacteria.
In urine (Supplemental Table 1 ), the abundant species L. iners was most enriched in women with a negative DOS result and a negative postoperative UTI status and most depleted in women with a positive DOS result and a positive postoperative UTI status. Several other abundant taxa were associated with a negative DOS result. In contrast, a few taxa were associated with a positive DOS result; OTUs in the family Enterobacteriaceae and the genus Pseudomonas were abundant and enriched in women who were DOS positive whether or not they developed a postoperative UTI. A few other taxa were associated with a positive DOS result, including members of the species Staphylococcus aureus, Klebsiella pneumoniae, Aerococcus christenesenii, and Prevotella denticola (Supplemental Table 1 ). Although postoperative UTI was most frequently associated with the urine microbiome, the microbiomes of the vagina and perineum also might be potential sources of pathogenic contribution. In the vagina (Supplemental Table  2 ), a few taxa were associated with a positive DOS result but not a positive UTI status. The species L. gasseri and an OTU of the family Enterobacteriaceae were both abundant and enriched in DOS-positive women; the less-abundant genus Veillonella and the species B. coagulans were also enriched in DOS-positive women. The genus Ureaplasma was enriched in DOS-positive women relative to DOSnegative women but most enriched in DOS-positive women with a positive postoperative UTI status. In the perineum (Supplemental Table 3 ), two taxa were enriched in women with a negative DOS result: an OTU in the genus Lactobacillus and the species C. tuberculostearicum. Others were enriched in women with a positive DOS result, including OTUs in the family Enterobacteriaceae and the genera Bifidobacterium and Peptoniphilus. Finally, a few taxa were enriched in women with a positive DOS result and a positive postoperative UTI status relative to women who were negative for both: the species Megasphaera massiliensis, B. coagulans, and B. fragilis, and an OTU in the genus Enterococcus.
Common OTUs in women with and without postoperative UTI As expected, some taxa were detected both in women who did and did not experienced a postoperative UTI. For the family Enterobactericeae and the genera Pseudomonas and Staphylococcus, one OTU was dominant regardless of UTI status (Fig. 2) . However, this was not true of the genus Lactobacillus; multiple OTUs were often detected in the same woman, and the composition of those OTUs differed by UTI status.
Discussion
Our findings support the hypothesis that risk of postoperative UTI is most frequently associated with the composition of the day-of-surgery microbiome of catheterized urine, suggesting a potential etiologic role for the bladder microbiome in postoperative UTI, a condition that may be more preventable than previously recognized. Risk of postoperative UTI was most often associated with depletion of certain Lactobacillus species, especially L. iners, and enrichment of certain uropathogens, especially members of the family Enterobacteriaceae (which includes Escherichia coli and Klebsiella pneumoniae) and the genus Pseudomonas (which includes P. aeruginosa).
Consistent with clinical observations, older patient age and absence of estrogen were clearly associated with an increased risk for postoperative UTI in urogynecologic surgical patients. This analysis provides important insight into the associated microbial mechanisms that may allow effective risk stratification through preoperative phenotyping. For most clinicians, absence of UTI-associated symptoms (variably defined) and/or negative urine testing (variably performed) has provided confidence that the patient does not have a current UTI. Yet, clearly, there is an opportunity to reduce the occurrence of postoperative UTI given our finding that most are related to d ep l e t i on of La c t o ba c i l l us an d e n r i c h m e nt o f uropathogens in the bladder prior to surgery. The findings from this analysis extend the impact of our prior analysis [11] , which demonstrated that a presurgical DOS standard urine culture effectively identifies a group of urogynecologic patients at increased short-term risk for UTI.
What specifically is different about older urogynecologic surgical patients that increases their postoperative UTI risk? Our findings demonstrate that there is a relative depletion of certain Lactobacillus species in their bladder microbiomes. Although the Lactobacillus OTUs present in the bladder are similar in women with and without UTI, there is a significant difference in the frequency and abundance, especially of L. iners. Clinicians have prescribed estrogen (often topically applied vaginal estrogen) with the intent of increasing or restoring vaginal Lactobacillus; these findings suggest that vaginal estrogen may also be a potential therapy for improving the bladder microbiome to reduce postoperative UTI risk. Depletion of L. iners was also associated with a more diverse microbial community with a higher risk of uropathogenic taxa. Further research will be necessary to determine whether presurgical application of vaginal estrogen in hypoestrogenic, older women is associated with a reduced risk of postoperative UTI. If so, one would hypothesize that the risk-reduction mechanism may be associated with a healthier perioperative bladder microbiome (more L. iners, fewer uropathogenic taxa, and the appropriate microbial diversity). Given the possibility of uropathogen reservoirs in the vagina and perineum, future studies should also include analysis of effects on these adjacent pelvic niches. As our knowledge of the bladder microbiome continues to expand, the simple dichotomous definition of UTI may need to be reconsidered [23] . We were intrigued to detect potential uropathogens in women who did not develop UTI. This may be related to a variety of biologic scenarios: (1) the immune system could resist infection, (2) the standard surgical prophylaxis effectively eradicated the organism, and/or (3) the bacterium detected by standard culture was a nonpathogenic strain of a known uropathogenic species. For example, we found that OTUs of Pseudomonas, a genus that includes a known uropathogen, were identical in women with and without UTI. This was also true for Staphylococcus. This finding should cause us to reconsider Bpathogenicity,^since at the genomic level these bacteria are identical (at least by the sequence of the 16S rRNA gene). For E. coli, other investigators have recently shown there is no genomic difference between strains associated with UTI or no UTI; the investigators report that the differences appear related to transcription rather than core genetics [24] .
As with all studies, there are limitations to this study, including the use of clinical characterization of hormonal status and a patient sample size that limited certain analysis for lesscommon microbes. In addition, this cohort was established prior to the development of enhanced culture protocols that more effectively identify urinary bacteria compared with the standard urine culture protocol, which has a high falsenegative rate [4, 25, 26] . There are known limitations to 16S rRNA gene sequencing, including taxonomic classification resolution for V4 regions and detection threshold for low biomass samples; however, sequencing generally detected bacteria identified by standard culture and numerous other bacteria that standard culture cannot detect.
Until additional information is available for UTI prevention efforts, clinicians should be cautious in modifying their current clinical practice. Although clinicians could initiate routine or selective preoperative (or day-of-surgery) urine culture testing to screen for women at increased UTI risk, standard urine culture results typically do not become available to the clinician until 24-48 h following initial plating. The window for optimal intervention may close prior to the availability of urine culture results. Culture-independent testing of urine is still a research tool that is not used for clinical care in the preoperative setting. There is currently no evidence for the clinical utility of rapid culture-independent diagnostics (sequencing or PCR of known or suspected uropathogens) that could expedite identification of individuals at increased risk for postoperative UTI.
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